“New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that having a lower level of zinc in the blood is associated with a poorer outcome in patients with COVID-19...
Mean baseline zinc levels among the 249 patients were 61 mcg/dl. Among those who died, the zinc levels at baseline were significantly lower at 43mcg/dl vs 63.1mcg/dl in survivors…
After adjusting by age, sex, severity and receiving hydroxychloroquine, statistical analysis showed each unit increase of plasma zinc at admission to hospital was associated with a 7% reduced risk of in-hospital mortality. Having a plasma zinc level lower than 50mcg/dl at admission was associated with a 2.3 times increased risk of in-hospital death compared with those patients with a plasma zinc level of 50mcg/dl or higher.”
© Medical Xpress 2011 - 2024 powered by Science X Network
Copyright Science X
https://sciencex.com/help/copyright/
For all other non-commercial uses of Science X content, such as blogs, Web sites and the like, we rely on the parameters of "Fair Use" as set forth in the Copyright Act. Users may copy, transfer or reproduce up to 200 words of an article or story and then insert a hyperlink back to the original content. By following these steps, no prior written or oral permission is required.